Moderna announces first patient dosed in mRNA-3705 study
Moderna have announced that the first patient has been dosed in Phase I/II study of mRNA-3705 for methylmalonic acidemia (MMA).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
